Company Filing History:
Years Active: 2020-2023
Title: Richard Parker-Manuel: Innovator in Retroviral Technology
Introduction
Richard Parker-Manuel is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors and transcription-promoting nucleic acid molecules. With a total of 2 patents, his work has the potential to impact various applications in genetic engineering and therapeutic development.
Latest Patents
Richard's latest patents include innovative technologies that enhance the production of retroviral packaging vectors. The first patent focuses on nucleic acid molecules that comprise viral genes or derivatives for use in retroviral packaging and producer cell lines. This invention includes specific configurations of env and gag-pol genes, which are crucial for effective retroviral vector production. The second patent relates to nucleic acid molecules capable of promoting transcription of operably-linked heterologous polynucleotides in mammalian cells. This technology also encompasses expression vectors and host cells that can produce recombinant proteins, such as antibodies and lentiviral polypeptides.
Career Highlights
Richard Parker-Manuel is associated with Oxford Genetics Limited, a company known for its advancements in genetic research and biotechnology. His work at the company has positioned him as a key player in the development of innovative solutions in the field.
Collaborations
Richard collaborates with talented individuals such as Ryan Cawood and Weiheng Su. Their combined expertise contributes to the success of their projects and the advancement of their research initiatives.
Conclusion
In summary, Richard Parker-Manuel is a distinguished inventor whose work in retroviral technology and genetic engineering is paving the way for future innovations. His contributions are vital to the ongoing advancements in biotechnology and therapeutic applications.